NCPIC - National Cannabis Prevention and Information Centre

Publications Bulletin - February 2012

Relevant publications examining issues to do with cannabis that have been published in the last month include the following:

  • Carbuto, M., Sewell, R.A., Williams, A., Forselius-Bielen, K., Braley, G., Elander, J., Pittman, B., Schnakenberg, A., Bhakta, S., Perry, E., Ranganathan, M., D'Souza, D.C. & The Yale THC Study Group. (2012). The safety of studies with intravenous Δ(9)-tetrahydrocannabinol in humans, with case histories. Psychopharmacology (Berl) 219, 885-896.
  • Deiana, S., Watanabe, A., Yamasaki, Y., Amada, N., Arthur, M., Fleming, S., Woodcock, H., Dorward, P., Pigliacampo, B., Close, S., Platt, B., & Riedel, G. (2012). Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour. Psychopharmacology (Berl) 219, 859-873.
  • Egashira, N., Manome, N., Mishima, K., Iwasaki, K., Oishi, R., & Fujiwara, M. (2012). Involvement of opioid system in cognitive deficits induced by ∆(9)-tetrahydrocannabinol in rats. Psychopharmacology (Berl) 219, 1111-1118.
  • Fagherazzi, E.V., Garcia, V.A., Maurmann, N., Bervanger, T., Halmenschlager, L.H., Busato, S.B., Hallak, J.E., Zuardi, A.W., Crippa, J.A., & Schröder, N. (2012). Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders. Psychopharmacology (Berl) 219, 1133-1140.
  • Farrimond, J.A., Whalley, B.J. & Williams, C.M. (2012). Non-Δ9tetrahydrocannabinol phytocannabinoids stimulate feeding in rats. Behavioural Pharmacology 23, 113-117.
  • Grant, J.E., Chamberlain, S.R., Schreiber, L., & Odlaug, B.L. (2012). Neuropsychological deficits associated with cannabis use in young adults. Drug and Alcohol Dependence 121, 159-162.
  • Hames, A., Evangeli, M., Harrop, C., & di Forti, M. (2012). Understanding cannabis use in first-episode psychosis: An application of the Theory of Planned Behaviour. Early Intervention in Psychiatry 6, 38-44.
  • Hayatbakhsh, M.R., Flenady, V.J., Gibbons, K.S., Kingsbury, A.M., Hurrion, E., Mamun, A.A., & Najman, J.M. (2012). Birth outcomes associated with cannabis use before and during pregnancy. Pediatric Research 71, 215-219.
  • Hesselink, J.M. & Kopsky, D.J. (2012). Intractable neuropathic pain due to ulnar nerve entrapment treated with cannabis and ketamine 10%. Journal of Clinical Anesthesia 24, 78-79.
  • Kumra, S., Robinson, P., Tambyraja, R., Jensen, D., Schimunek, C., Houri, A., Reis, T., & Lim, K. (2012). Parietal lobe volume deficits in adolescents with schizophrenia and adolescents with cannabis use disorders. Journal of the American Academy of Child and Adolescent Psychiatry 51, 171-180.
  • Maxwell, J.C. (2012). Drunk versus drugged: How different are the drivers? Drug and Alcohol Dependence 121, 68-72.
  • Mayet, A., Legleye, S., Falissard, B., & Chau, N. (2012). Cannabis use stages as predictors of subsequent initiation with other illicit drugs among French adolescents: Use of a multi-state model. Addictive Behaviors 37, 160-166.
  • Tormey, W., Moore, T. & Gulmann, C. (2012). Cannabis smoking and myocardial infarction. International Journal of Clinical Practice 66, 226.
  • Tormey, W.P. (2012). Royal College of Pathologists' autopsy guidelines on sudden cardiac death: Roles for cannabis, cotinine, NSAIDs and psychology. Journal of Clinical Pathology 65, 187-188.
  • van Gastel, W.A., Wigman, J.T., Monshouwer, K., Kahn, R.S., van Os, J., Boks, M.P., & Vollebergh, W.A. (2012). Cannabis use and subclinical positive psychotic experiences in early adolescence: Findings from a Dutch survey. Addiction 107, 381-387.
  • Weissenborn, R. & Nutt, D.J. (2012). Popular intoxicants: What lessons can be learned from the last 40 years of alcohol and cannabis regulation? Journal of Psychopharmacology 26, 213-220.